Ocean Biomedical is a 21st century biopharma company that partners with leading scientists, research universities, and medical centers to solve unmet medical needs by accelerating the translation of new discoveries into breakthrough medicines.
We're working to bridge the “bench-to-bedside” gap between medical inventions and patient solutions, to solve pressing medical problems throughout the world. Our team of accomplished scientists, business professionals, technology transfer leaders and entrepreneurs is focused on bringing together the expertise and resources required to commercialize a diverse portfolio of pharmaceutical candidates.
Ocean Biomedical aims to build a continuous pipeline of drug development opportunities through our relationships with universities and medical centers. We are organized around a licensing and subsidiary structure that we believe will enable us to create mutual value for our shareholders and licensing partners.
We are currently pursuing programs in oncology, fibrosis, infectious disease, and inflammation. We anticipate moving certain preclinical product candidates in our oncology, fibrosis and/or infectious disease programs into the clinic in the next 12 to 18 months.
Ocean Biomedical is building powerful partnerships to advance promising medical innovations from lab to market, backing creative scientists who are bringing new perspectives to the most complex problems facing medicine and society today.
